持田製薬(株)の貸借残高情報
主市場 | 業種 | 証券コード/EDINET | 英名称 |
---|
東証PRM | 医薬品 | 4534/E00947 | - |
公表日 | 公表 | 貸付残高 | 前週比 | 新規貸付成約高 | 前週比 | 借入残高 | 前週比 | 新規借入成約高 | 前週比 |
---|
2013/07/12 | 日証協 | 742,610株 | +28.57% | 724,300株 | +23.39% | 918,006株 | +84.9% | 718,520株 | +644.73% |
2013/07/05 | 日証協 | 577,610株 | -13.35% | 587,000株 | -13.93% | 496,486株 | -5.79% | 96,480株 | +124.35% |
2013/06/28 | 日証協 | 666,610株 | +5.54% | 682,000株 | +31.7% | 527,010株 | +6.04% | 43,004株 | -1.19% |
2013/06/21 | 日証協 | 631,610株 | -1.1% | 517,850株 | -33.21% | 497,006株 | -6.66% | 43,520株 | -54.19% |
2013/06/14 | 日証協 | 638,610株 | -6.03% | 775,300株 | -8.05% | 532,486株 | -2.74% | 95,000株 | +30.14% |
2013/06/07 | 日証協 | 679,610株 | -2.84% | 843,160株 | -12.37% | 547,486株 | +4.39% | 73,000株 | +25.86% |
2013/05/31 | 日証協 | 699,450株 | +11.32% | 962,160株 | +28.24% | 524,486株 | +0.6% | 58,001株 | -53.6% |
2013/05/24 | 日証協 | 628,312株 | +32.43% | 750,300株 | +69.37% | 521,347株 | +12.97% | 125,000株 | +47.06% |
2013/05/17 | 日証協 | 474,450株 | -4.25% | 443,000株 | +5.23% | 461,485株 | +0.64% | 85,000株 | +844.44% |
2013/05/10 | 日証協 | 495,524株 | -1.2% | 421,000株 | -7.06% | 458,559株 | -4.18% | 9,000株 | 0% |
2013/05/02 | 日証協 | 501,524株 | +3.08% | 453,000株 | +62.41% | 478,559株 | -4.4% | 0株 | -100% |
2013/04/26 | 日証協 | 486,524株 | -0.82% | 278,924株 | +40.16% | 500,559株 | +0.6% | 12,000株 | -87.6% |
2013/04/19 | 日証協 | 490,524株 | +5.6% | 199,000株 | -1% | 497,559株 | -0.99% | 96,786株 | +136.06% |
2013/04/12 | 日証協 | 464,524株 | -4.52% | 201,000株 | -46.83% | 502,559株 | -8.39% | 41,000株 | -51.19% |
2013/04/05 | 日証協 | 486,524株 | +21.41% | 378,000株 | +87.13% | 548,559株 | +20.24% | 84,000株 | +36.96% |
2013/03/29 | 日証協 | 400,724株 | +33.7% | 202,000株 | -46.46% | 456,228株 | +18.64% | 61,331株 | -78.56% |
2013/03/22 | 日証協 | 299,724株 | -12.03% | 377,282株 | +113.15% | 384,559株 | +4.58% | 286,009株 | +157.45% |
2013/03/15 | 日証協 | 340,724株 | -17.64% | 177,000株 | -49.03% | 367,726株 | -20.43% | 111,091株 | +184.85% |
2013/03/08 | 日証協 | 413,724株 | -20.85% | 347,273株 | +49.73% | 462,167株 | -14.12% | 39,000株 | -0.06% |
※株式分割は考慮していませんのでご注意ください。
Page Top